Incidence and risk factors for development of hepatocellular carcinoma at young age in patients with chronic hepatitis B

被引:7
|
作者
Goh, Myung Ji [1 ]
Kang, Wonseok [1 ,2 ,3 ]
Kim, Kwang Min [4 ]
Sinn, Dong Hyun [1 ]
Gwak, Geum-Youn [1 ]
Paik, Yong-Han [1 ]
Choi, Moon Seok [1 ]
Lee, Joon Hyeok [1 ]
Koh, Kwang Cheol [1 ]
Paik, Seung Woon [1 ]
机构
[1] Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Sch Med, 81 Irwon Ro, Seoul 06351, South Korea
[2] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea
[3] Samsung Med Ctr, Res Inst Future Med, Seoul, South Korea
[4] Sungkyunkwan Univ, Samsung Changwon Hosp, Dept Med, Sch Med, Chang Won, South Korea
基金
新加坡国家研究基金会;
关键词
Hepatocellular carcinoma; surveillance; FIB-4; young; chronic hepatitis B; INDEX; PROGNOSIS; FEATURES; FIBROSIS; CANCER;
D O I
10.1080/00365521.2021.1988700
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Some young adults with chronic hepatitis B virus (HBV) infection might be at high risk for hepatocellular carcinoma (HCC), enough to justify regular HCC surveillance despite the young age of the patients. However, ways to identify at-risk individuals who may benefit from HCC surveillance need further evaluations. Methods A hospital-based retrospective cohort of 2757 chronic HBV mono-infected young adults (median age: 34 years, males 66%) were analyzed. The primary outcome was young-onset HCC, defined as a diagnosis made under 40 years of age. We calculated the HCC incidence/1000 person-years in the overall cohort and pre-defined subgroups of patients assessed the independent risk factors that can be used to identify surveillance targets. Results The HCC incidence was low (2.55/1000 person-years) in the overall cohort. However, the HCC incidence varied widely according to baseline characteristics: lowest among young adults with FIB-4 <= 0.70 (0.17/1000 person-years) and highest in young adults with radiological cirrhosis (30.7/1000 person-years). In multivariable analysis, radiological cirrhosis, the FIB-4 index, and serum HBV DNA level were independent factors associated with HCC development at a young age. Performance for prediction of young-onset HCC in radiological cirrhotic patients showed the highest specificity but sensitivity was Conclusion Risk stratification using FIB-4 index, HBV DNA levels, and either combining radiological cirrhosis or gender and AFP levels would be helpful to stratify young patients who would and would not benefit from regular HCC surveillance.
引用
收藏
页码:70 / 77
页数:8
相关论文
共 50 条
  • [21] Hepatocellular carcinoma among US and non US-born patients with chronic hepatitis B: Risk factors and age at diagnosis
    Kennedy, Kaitlyn
    Graham, Susan M.
    Arora, Nayan
    Shuhart, Margaret C.
    Kim, H. Nina
    PLOS ONE, 2018, 13 (09):
  • [22] Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
    Goh, Myung Ji
    Sinn, Dong Hyun
    Kim, Seonwoo
    Woo, Sook Young
    Cho, Hyun
    Kang, Wonseok
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    HEPATOLOGY, 2020, 71 (06) : 2023 - 2032
  • [23] Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection
    Ito, Kenichi
    Arai, Makoto
    Imazeki, Fumio
    Yonemitsu, Yutaka
    Bekku, Dan
    Kanda, Tatsuo
    Fujiwara, Keiichi
    Fukai, Kenichi
    Sato, Kenichi
    Itoga, Sakae
    Nomura, Fumio
    Yokosuka, Osamu
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 (02) : 243 - 249
  • [24] Insulin resistance and the risk of hepatocellular carcinoma in chronic hepatitis B patients
    Kim, Jung Hee
    Sinn, Dong Hyun
    Gwak, Geum-Youn
    Kang, Wonseok
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (05) : 1100 - 1106
  • [25] Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B
    Shin, Haneulsaem
    Jung, Yeon Woo
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    Kim, Yeun-Yoon
    Choi, Jin-Young
    Kim, Seung Up
    CLINICAL AND MOLECULAR HEPATOLOGY, 2019, 25 (04) : 390 - 399
  • [26] Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C in China and the US
    Yang, Ming
    Parikh, Neehar D.
    Liu, Huixin
    Wu, Elizabeth
    Fu, Sherry
    Rao, Huiying
    Feng, Bo
    Lin, Andy
    Fei, Ran
    Wei, Lai
    Lok, Anna S.
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E852 - E852
  • [27] MULTICENTER STUDY ON INCIDENCE AND RISK FACTORS OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH AUTOIMMUNE HEPATITIS
    Yang, Jiwon
    Yim, Sun Young
    Kim, Kunhee
    Lee, Hye Won
    Choi, Jonggi
    HEPATOLOGY, 2024, 80 : S1805 - S1805
  • [28] The Incidence and Risk Factors for the Development of Hepatocellular Carcinoma after Peginterferon plus Ribavirin Therapy for Chronic Hepatitis C
    Dohmen, Kazufumi
    Kawano, Akira
    Takahashi, Kazuhiro
    Shigematsu, Hirohisa
    Tanaka, Hirofumi
    Haruno, Masatora
    Yanagita, Kimihoko
    Ichiki, Yasunori
    Mori, Tetsu
    Hayashida, Kazuhiro
    Shimoda, Shinji
    Ishibashi, Hiromi
    Nomura, Hideyuki
    HEPATO-GASTROENTEROLOGY, 2013, 60 (128) : 2034 - 2038
  • [29] Predictive Factors Associated with Hepatocellular Carcinoma Incidence and Mortality after Hepatitis B Surface Antigen Seroclearance in Patients with Chronic Hepatitis B
    Hosaka, Tetsuya
    Suzuki, Fumitaka
    Kobayashi, Masahiro
    Fujiyama, Shunichiro
    Kawamura, Yusuke
    Sezaki, Hitomi
    Akuta, Norio
    Suzuki, Yoshiyuki
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kobayashi, Mariko
    Kumada, Hiromitsu
    HEPATOLOGY, 2018, 68 : 133A - 134A
  • [30] RISK FACTORS AND PROGNOSTIC SCORES ASSOCIATED WITH HEPATOCELLULAR CARCINOMA DEVELOPMENT IN PATIENTS WITH HEPATITIS B VIRUS
    Pastras, Ploutarchos
    Zazas, Evangelos
    Kalafateli, Maria
    Aggeletopoulou, Ioanna
    Tsounis, Efthymios
    Kanaloupitis, Stavros
    Zisimopoulos, Konstantinos
    Kottaridou, Eleni-Eirini-Konstantina
    Antonopoulou, Aspasia
    Drakopoulos, Dimosthenis
    Diamantopoulou, Georgia
    Tsintoni, Aggeliki
    Thomopoulos, Konstantinos
    Triantos, Christos
    HEPATOLOGY, 2023, 78 : S1410 - S1411